Recently, VivaLNK announced the availability of their new wearable medical device, the Vitals Data Service. About the new service, VivaLNK said Vitals Data Service is a turnkey service ideal for use in clinical trials and healthcare in remote or clinical settings. The service’s features include VivaLNK’s line of FDA-cleared ambulatory medical wearable sensors, a customizable remote patient monitoring app, cloud and data concierge services for consolidated and customizable data access points.
The Vitals Data Service is poised to be used in upcoming pharmaceutical clinical trials for hypertension and neurological drug development. Some universities have picked up VivaLNK’s new platform as well, including UCSF, which is using it for an atrial fibrillation study, and Stanford University, which is using the service on a study of the effects of stress and teenage depression. If VivaLNK’s new platform delivers all that is promised, this could be a game-changer for researchers, as Vitals Data Service provides a continuous dataset for analysis, regardless of where the patient is located.
Jiang Li, CEO of VivaLNK said, “The launch of the Vitals Data Service is an important step towards enabling the diverse and ever growing need to bring life-changing healthcare applications to market.” He continued, “The next generation of medical application and drug discovery is dependent on the ability to rapidly analyze continuous streams of data in order to understand a more complete picture of human physiology.”
Data included with the Vitals Data Service include ECG rhythm, heart rate, respiratory rate, oxygen saturation, and accelerometer.
Those interested in learning more about VivaLNK should visit www.VivaLNK.com.